Research & Development
Leica Microsystems wins US FDA's 510(k) clearance for augmented reality GLOW800 vascular fluorescence for vascular neurosurgery
21 September 2018 -

Microscope company Leica Microsystems reported on Thursday the receipt of the US Food and Drug Administration's (FDA) 510(k) clearance to market its augmented reality GLOW800 surgical fluorescence for vascular neurosurgery.

The company said the GLOW800 and ICG (Indocyanine Green) combination allows surgeons to observe cerebral anatomy in natural colour, augmented by real-time vascular flow in a single image, with full depth perception, providing the surgeon a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery.

According to the company, GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR, which can be fully integrated in the ARveo digital augmented reality microscope which launched earlier this year.

With the US FDA's 510(k) clearance of GLOW800, the company's customers in the US can now experience the full advantages of augmented reality visualisation in the operating room.



Related Headlines